Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
CAAM Logo
CAAM CB Rank
616037
Heat Score
61
CAAM operates a facility that researches on various allergic diseases.
Founded
obfuscation
Private Sermoneta, Lazio, Italy www.caam-allergy.com/en
Clinical Trials
Health Care
Health Diagnostics
Medical
Overview

CAAM
Heat Score
61

Growth Score
pts
in past quarter
Heat Score 61
10 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About CAAM

CB Rank
616037
CAAM operates a facility that researches on various allergic diseases.
Founded
obfuscation
Private Sermoneta, Lazio, Italy www.caam-allergy.com/en
Clinical Trials
Health Care
Health Diagnostics
Medical

Key People

Details

Legal Name Sermolab S.r.l.
Also Known As Centri Associati di Allergologia Molecolare
Operating Status Active
Company Type For Profit
About the Company
CAAM operates a facility that researches on various allergic diseases. It provides clinical activities to study and develop treatment for allergies. CAAM was founded in 2013 and is based in Latina. Italy.
Phone Number +39 348 272 0 372
Contact Email caam.allergy@gmail.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

FABER IgE Test
A multiplex nanobead-based IgE diagnostic test for identifying allergic sensitizations to a broad panel of allergenic molecules and extracts.
Allergome Platform
A web-based database platform that collects, organizes, and updates scientific data on allergenic molecules and related literature.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Employee Profiles 1 Contacts 1

Employee Profiles

News

News and Press

News•Apr 27, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jan 11, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Nov 6, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jul 8, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

95
-30.66%
 in past month

IT Spend

$72.6KThis year, CAAM is projected to spend $72.6K on IT, according to Aberdeen.

Active Website Tech Count

2CAAM is actively using 2 technologies for its website, according to BuiltWith. These include Viewport Meta, IPhone / Mobile Compatible, and  Common Crawl.
Sub-Organizations
Frequently Asked Questions

Where is CAAM's headquarters? CAAM is located in Sermoneta, Lazio, Italy.Who are CAAM's competitors? Alternatives and possible competitors to CAAM may include Patient Square Capital, Dr. Fooke Laboratorien, and  DST Diagnostische Systeme & Technologien.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(be4ac66 1)
|